文献速递呼吸道感染慢阻肺哮喘

CPFE临床结局与急性加重发生率:多中心前瞻性研究

Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema
RSS 订阅 · Respirology · 2026-07-08

该多中心前瞻性研究纳入1016例IIP或COPD患者,按国际标准以CT视觉评估≥5%肺气肿定义CPFE。CPFE患者5年生存率51.4%,显著低于非CPFE IIP的63.1%和COPD的84.0%,且急性加重发生率更高;调整协变量后CPFE仍独立关联死亡风险(HR 1.85,95%CI 1.27–2.69,p<0.001)。

要点

  • CPFE以CT视觉评估≥5%肺气肿为界,可识别高死亡风险表型。
  • CPFE患者5年生存率51.4%,低于非CPFE IIP和COPD患者。
  • CPFE患者急性加重率显著高于非CPFE IIP患者(p<0.001)。

核心结论

  • CT视觉评估≥5%肺气肿阈值可有效识别CPFE患者,该表型生存差且急性加重发生率高。
  • CPFE在IIP患者中独立关联死亡风险增加(HR 1.85,95%CI 1.27–2.69,p<0.001)。

研究设计与样本

  • 多中心前瞻性队列研究,纳入29家日本医院2013–2016年1016例IIP或COPD患者。
  • CPFE定义为IIP患者CT视觉评估肺气肿≥5%,随访5年。

主要发现

  • 528例IIP患者中92例(17.4%)为CPFE。
  • CPFE患者5年生存率51.4%,非CPFE IIP患者为63.1%(p=0.026),COPD患者为84.0%(p<0.001)。
  • CPFE患者急性加重率显著高于非CPFE IIP患者(p<0.001)。
  • CPFE的预后影响在IPF患者中最显著,CPFE/IPF患者结局最差。

关键数值与推荐

  • CPFE诊断标准:IIP患者CT视觉评估肺气肿≥5%。
  • CPFE患者5年生存率51.4%,非CPFE IIP 63.1%,COPD 84.0%。
  • CPFE vs 非CPFE IIP的5年生存率比较p=0.026;CPFE vs COPD比较p<0.001。
  • 调整协变量后CPFE与死亡风险关联HR 1.85(95%CI 1.27–2.69),p<0.001。

临床怎么用

  • 对IIP患者应行CT视觉评估肺气肿范围,≥5%可识别CPFE高危表型。
  • CPFE患者需加强监测急性加重并考虑个体化管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This multicentre prospective study of 1016 patients demonstrated that CPFE, defined as ≥ 5% emphysema on visual CT assessment, identified a high-risk phenotype with significantly worse 5-year survival compared to non-CPFE IIP patients (51.4% vs. 63.1%) and COPD patients (51.4% vs. 84.0%) and higher acute exacerbation incidence, validating international classification criteria. ABSTRACT Background and Objective Combined pulmonary fibrosis and emphysema (CPFE) is characterized by coexisting upper-zone emphysema and lower-zone fibrosis, but standardized diagnostic criteria and clinical outcomes remain poorly defined. This study aimed to evaluate survival, acute exacerbation incidence, and disease progression in CPFE patients using international classification criteria with visual assessment of emphysema extent. Methods This multicentre prospective cohort study at 29 Japanese hospitals enrolled 1016 patients with idiopathic interstitial pneumonias (IIPs) or chronic obstructive pulmonary disease (COPD) between 2013 and 2016. CPFE was defined as ≥ 5% emphysema determined by visual assessment of CT scans for IIP patients, according to international classification criteria. Patients were followed for 5 years. Results Among 528 IIP patients, 92 (17.4%) had CPFE. CPFE patients showed a significantly worse 5-year survival compared with non-CPFE IIP patients (51.4% vs. 63.1%, p = 0.026) and COPD patients (51.4% vs. 84.0%, p < 0.001). After adjustment for covariates including IIP subtype, CPFE remained independently associated with increased mortality among IIP patients (HR of 1.85 [95% CI, 1.27–2.69], p < 0.001). CPFE patients also had a significantly higher acute exacerbation rate than did non-CPFE IIP patients (p < 0.001). The prognostic impact of CPFE was most pronounced in patients with idiopathic pulmonary fibrosis (IPF), with CPFE/IPF patients showing the worst outcomes. Conclusion Visual assessment with a ≥ 5% emphysema threshold effectively identified CPFE patients with a distinct clinical phenotype characterized by poor survival and an increased acute exacerbation incidence. These findings validate international classification criteria and emphasize the need for enhanced surveillance and tailored management strategies for this high-risk population.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Respirology:Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。